Pharmaceuticals Companies By Roa
LargestBiggest EarnersMost ProfitableMost LiquidHighly LeveragedTop DividendsCapital-HeavyHighest ValuationLargest Workforce
Return On Asset
| ROA | Efficiency | Market Risk | Exp Return | ||||
|---|---|---|---|---|---|---|---|
| 1 | NVO | Novo Nordisk AS | (0.11) | 3.85 | (0.44) | ||
| 2 | TBET | Tibet Pharmaceuticals | 0.00 | 0.00 | 0.00 | ||
| 3 | LLY | Eli Lilly and | 0.03 | 1.92 | 0.05 | ||
| 4 | ZTS | Zoetis Inc | (0.09) | 1.57 | (0.15) | ||
| 5 | SIGA | SIGA Technologies | 0.15 | 2.26 | 0.34 | ||
| 6 | MRK | Merck Company | 0.05 | 1.89 | 0.10 | ||
| 7 | HRMY | Harmony Biosciences Holdings | 0.03 | 2.07 | 0.06 | ||
| 8 | NVS | Novartis AG ADR | 0.09 | 1.30 | 0.12 | ||
| 9 | RDY | Dr Reddys Laboratories | 0.05 | 1.49 | 0.08 | ||
| 10 | INVA | Innoviva | 0.00 | 1.39 | 0.00 | ||
| 11 | CORT | Corcept Therapeutics Incorporated | 0.00 | 2.47 | 0.01 | ||
| 12 | BMY | Bristol Myers Squibb | 0.00 | 1.92 | 0.00 | ||
| 13 | CRMD | CorMedix | 0.02 | 4.45 | 0.10 | ||
| 14 | AZN | AstraZeneca PLC ADR | 0.11 | 1.58 | 0.18 | ||
| 15 | COLL | Collegium Pharmaceutical | 0.13 | 1.74 | 0.23 | ||
| 16 | JNJ | Johnson Johnson | 0.14 | 1.31 | 0.18 | ||
| 17 | AMPH | Amphastar P | (0.10) | 2.12 | (0.21) | ||
| 18 | RPRX | Royalty Pharma Plc | 0.18 | 1.30 | 0.24 | ||
| 19 | OGN | Organon Co | (0.02) | 3.05 | (0.07) | ||
| 20 | AMRX | Amneal Pharmaceuticals, Class | 0.09 | 1.81 | 0.16 |
The analysis above is based on a 90-day investment horizon and a default level of risk. Use the Portfolio Analyzer to fine-tune all your assumptions. Check your current assumptions here.
Return on Asset or ROA shows how effective is the management of the company in generating income from utilizing all of the assets at their disposal. It is a useful ratio to evaluate the performance of different departments of a company as well as to understand management performance over time. Return on Asset measures overall efficiency of a company in generating profits from its total assets. It is expressed as the percentage of profits earned per dollar of Asset. A low ROA typically means that a company is asset-intensive and therefore will needs more money to continue generating revenue in the future.